Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy

Ann Hematol. 2022 Dec;101(12):2805-2806. doi: 10.1007/s00277-022-05006-3. Epub 2022 Oct 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefiderocol
  • Cephalosporins / therapeutic use
  • Gram-Negative Bacterial Infections* / drug therapy
  • Hematologic Neoplasms* / drug therapy
  • Humans
  • Pneumonia* / drug therapy
  • Stenotrophomonas maltophilia*

Substances

  • Cephalosporins
  • Anti-Bacterial Agents